SCHEMBL19909499

SCHEMBL19909499

Cc1ccc(-c2ccc3c4ccc(-c5ccc(C)cc5C)cc4n(-c4cc(C#N)cc(-n5c6cc(-c7ccc(C)cc7C)ccc6c6ccc(-c7ccc(C)cc7C)cc65)c4-c4ccncc4)c3c2)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
FLT3 P36888 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
ABL1 P00519 1/20 0.34
CHEK1 O14757 2/20 0.33
MAPK14 Q16539 3/20 0.33
SLC2A1 P11166 1/20 0.32
CSNK1A1 P48729 1/20 0.32
CSNK1D P48730 1/20 0.32
GRM2 Q14416 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
KCNH2 Q12809 2/20 0.31
EGLN2 Q96KS0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913162 0.95 FLT3 (0.36) CYP11B1CYP11B2FLT3TDP1MEN1
SCHEMBL19909500 0.91 CYP11B1 (0.38) CYP11B1CYP11B2FLT3TDP1MEN1
SCHEMBL19909070 0.89 CYP11B1 (0.35) CYP11B1CYP11B2FLT3TDP1MEN1
SCHEMBL21414255 0.89 ALDH1A1 (0.32) CYP11B1CYP11B2CHEK1GRM2
SCHEMBL19913138 0.89 MAPK14 (0.36) FLT3TDP1MAPK14CSNK1A1CSNK1D
SCHEMBL19908896 0.88 CYP11B1 (0.39) CYP11B1CYP11B2FLT3TDP1ABL1
SCHEMBL19908960 0.88 MAPK14 (0.36) CYP11B1CYP11B2FLT3TDP1ABL1
SCHEMBL19913167 0.88 CYP2C9 (0.32) CYP11B1CYP11B2FLT3
SCHEMBL19913161 0.88 FLT3 (0.40) FLT3TDP1CHEK1MAPK14CSNK1A1
SCHEMBL19913287 0.87 GRM2 (0.34) CYP11B1CYP11B2CHEK1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 CYP11B1 610/4885CYP11B2 402/4885FLT3 2571/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 CYP11B1 610/4885CYP11B2 402/4885FLT3 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.